Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of quadrivalent HPV vaccination in immunosuppressed girls
2011-006002-27Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of qHPV vaccine in human papillomavirus infection, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Seroconversion rate for HPV 16 and 18 at month 18. Started Jan 2012; status: active.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on 2011-006002-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006002-27.